Fabrizio, A.M. (1965) An induced transmissible sarcoma in hamsters: eleven-year observation through 288 passages, Cancer Research 25: 107–117

Banfield, W.G., Woke, P.A., Mackay, C.M., and Cooper, H.L. (1965) Mosquito transmission of a reticulum cell sarcoma of hamsters, Science 148: 1239–1240 doi:10.1126/ science.148.3674.1239

ГЛАВА 9

Marquart, J., Chen, E.Y. and Prasad V. (2018) Estimation of the percentage of US patients with cancer who benefit from genome-driven oncology, JAMA Oncol. 4: 1093–1098 doi:10.1001/jamaoncol.2018.1660

Abola, M.V., Prasad, V. (2016) The use of superlatives in cancer research, JAMA Oncol. 2: 139–141 doi:10.1001/ jamaoncol.2015.3931

Kuderer, N. M., Burton, K. A., Blau, S. et al. (2017) Comparison of 2 commercially available next-generation sequencing platforms in oncology, JAMA Oncology 3: 996–998 doi:10.1001/jamaoncol.2016.4983

Prahallad, A., Sun, C., Huang, S. et al. (2012) Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR, Nature 483: 100–103 doi:10.1038/nature10868

Prasad V. (2017) Overestimating the benefit of cancer drugs, JAMA Oncol. 3: 1737–1738 doi: 10.1001/jamaoncol.2017.0107

Salas-Vega, S., Iliopoulos, O. and Mossialos, E. (2017) Assessment of overall survival, quality of life, and safety benefits associated with new cancer medicines, JAMA Oncol. 3: 382–390 doi:10.1001/jamaoncol.2016.4166

Fojo, T., Mailankody, S. and Lo, A. (2014) Unintended consequences of expensive cancer therapeutics – the pursuit of marginal indications and a Me-Too mentality that stifles innovation and creativity: The John Conley Lecture, JAMA Otolaryngol Head Neck Surg. 140:1225–1236 doi:10.1001/ jamaoto.2014.1570